Peer-reviewedCC BY 4.0Eurosurveillance
Maternal RSV vaccination in the absence of a nationally funded programme: inequalities in coverage in Norway, 2024 to 2026
- 1Norwegian Institute of Public Health, Oslo, Norway
Abstract
Respiratory syncytial virus (RSV) is a leading cause of hospitalisation for lower respiratory tract infection in children. Despite not being included in Norway’s national immunisation programme and requiring out-of-pocket payment, maternal RSV vaccination coverage reached 51% by September 2026. Coverage varied markedly by maternal country of birth, with lower uptake among women born outside Norway. Within Oslo, uptake appeared to reflect district-level socioeconomic factors. These inequalities suggest that lack of government funding is an important driver of unequal protection.
Related
- Global variations in breast cancer screening coverage and programme indicators: an evidence analysis of multi-source data from 75 countries/regions
- Household cooking fuels, symptoms compatible with pneumonia and inequalities in care seeking among children under five in the Republic of the Congo: a nationally representative survey analysis
- Hepatitis B vaccination coverage and factors associated with higher uptake among children aged 5–35 months in eight selected sub-Saharan African countries: a multilevel ordinal logistic regression analysis
- Environmental heavy metal exposure, socioeconomic inequalities, and childhood anaemia in Bangladesh: a nationally representative, survey-weighted Bayesian hierarchical analysis
- HPV vaccination coverage and barriers for people with disability: A scoping review.
BibTeX
@article{skar2026maternal,
title = {{Maternal RSV vaccination in the absence of a nationally funded programme: inequalities in coverage in Norway, 2024 to 2026}},
author = {Fredrik Skår and Hinta Meijerink and Margrethe Greve-Isdahl and Anja Bråthen Kristoffersen and Jacob Dag Berild and Suzanne Campbell and Håkon Bøås},
journal = {Eurosurveillance},
year = {2026},
month = nov,
doi = {10.2807/1560-7917.es.2026.31.44.2600882},
url = {https://doi.org/10.2807/1560-7917.es.2026.31.44.2600882},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Maternal RSV vaccination in the absence of a nationally funded programme: inequalities in coverage in Norway, 2024 to 2026
AU - Fredrik Skår
AU - Hinta Meijerink
AU - Margrethe Greve-Isdahl
AU - Anja Bråthen Kristoffersen
AU - Jacob Dag Berild
AU - Suzanne Campbell
AU - Håkon Bøås
PY - 2026
DA - 2026/11/05
JO - Eurosurveillance
DO - 10.2807/1560-7917.es.2026.31.44.2600882
UR - https://doi.org/10.2807/1560-7917.es.2026.31.44.2600882
AB - Respiratory syncytial virus (RSV) is a leading cause of hospitalisation for lower respiratory tract infection in children. Despite not being included in Norway’s national immunisation programme and requiring out-of-pocket payment, maternal RSV vaccination coverage reached 51% by September 2026. Coverage varied markedly by maternal country of birth, with lower uptake among women born outside Norway. Within Oslo, uptake appeared to reflect district-level socioeconomic factors. These inequalities suggest that lack of government funding is an important driver of unequal protection.
SN - 1025-496X
SN - 1560-7917
ER -